Articles - 5o08 mentioned but not cited (1)
- Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design. Thomas SE, McCarthy WJ, El Bakali J, Brown KP, Kim SY, Blaszczyk M, Mendes V, Abell C, Floto RA, Coyne AG, Blundell TL. Front Mol Biosci 9 880432 (2022)
Reviews citing this publication (6)
- In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery. de Souza Neto LR, Moreira-Filho JT, Neves BJ, Maidana RLBR, Guimarães ACR, Furnham N, Andrade CH, Silva FP. Front Chem 8 93 (2020)
- Structure-based drug design: aiming for a perfect fit. van Montfort RLM, Workman P. Essays Biochem 61 431-437 (2017)
- Current Strategies and Applications for Precision Drug Design. Wang C, Xu P, Zhang L, Huang J, Zhu K, Luo C. Front Pharmacol 9 787 (2018)
- The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies. Waman VP, Sen N, Varadi M, Daina A, Wodak SJ, Zoete V, Velankar S, Orengo C. Brief Bioinform 22 742-768 (2021)
- Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery. Waman VP, Vedithi SC, Thomas SE, Bannerman BP, Munir A, Skwark MJ, Malhotra S, Blundell TL. Emerg Microbes Infect 8 109-118 (2019)
- Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges. Togre NS, Vargas AM, Bhargavi G, Mallakuntla MK, Tiwari S. Int J Mol Sci 23 10669 (2022)
Articles citing this publication (10)
- Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry. Lai YT, Wang T, O'Dell S, Louder MK, Schön A, Cheung CSF, Chuang GY, Druz A, Lin B, McKee K, Peng D, Yang Y, Zhang B, Herschhorn A, Sodroski J, Bailer RT, Doria-Rose NA, Mascola JR, Langley DR, Kwong PD. Nat Commun 10 47 (2019)
- Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping. Thomas SE, Collins P, James RH, Mendes V, Charoensutthivarakul S, Radoux C, Abell C, Coyne AG, Floto RA, von Delft F, Blundell TL. Philos Trans A Math Phys Eng Sci 377 20180422 (2019)
- Targeting Allostery with Avatars to Design Inhibitors Assessed by Cell Activity: Dissecting MRE11 Endo- and Exonuclease Activities. Moiani D, Ronato DA, Brosey CA, Arvai AS, Syed A, Masson JY, Petricci E, Tainer JA. Methods Enzymol 601 205-241 (2018)
- Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing. Ozdemir ES, Halakou F, Nussinov R, Gursoy A, Keskin O. Methods Mol Biol 1903 1-21 (2019)
- Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification. Thomas SE, Whitehouse AJ, Brown K, Burbaud S, Belardinelli JM, Sangen J, Lahiri R, Libardo MDJ, Gupta P, Malhotra S, Boshoff HIM, Jackson M, Abell C, Coyne AG, Blundell TL, Floto RA, Mendes V. Nucleic Acids Res 48 8099-8112 (2020)
- An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV-1 protease variants. Nayak C, Chandra I, Singh SK. J Cell Biochem 120 9063-9081 (2019)
- Predicting the Effect of Chemical Factors on the pH of Crystallization Trials. Wilson J, Ristic M, Kirkwood J, Hargreaves D, Newman J. iScience 23 101219 (2020)
- FGDB: a comprehensive graph database of ligand fragments from the Protein Data Bank. Toti D, Macari G, Barbierato E, Polticelli F. Database (Oxford) 2022 baac044 (2022)
- Mapping Single-Molecule Protein Complexes in 3D with DNA Nanoswitch Calipers. Shrestha P, Yang D, Ward A, Shih WM, Wong WP. J Am Chem Soc 145 27916-27921 (2023)
- Historical Article Marking the Milestones in Structural Biology. Wright PE, Hodak H. J Mol Biol 429 2591-2593 (2017)